Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop ...
The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.
A new study suggests blockbuster weight loss drugs Wegovy and Zepbound are not cost-effective at their current prices, despite the proven health benefits. The study, published in JAMA Health Forum and ...
People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...
A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...
The exact price depends on dosage, pharmacy, location, insurance coverage, and available savings programs. Fully ...
Novo Nordisk announced a direct-to-consumer program that allows patients to buy Wegovy out of pocket at a lower cost.
Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...
The diabetes and weight loss drug market is heating up in 2025, with significant growth signs everywhere. According to a recent study from Research and Markets, industry growth is running at an ...
Adults with obesity who have a prescription for Wegovy but do not have insurance coverage for the drug can now purchase the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results